In liver cancer, Ma et al.86 reported that METTL14 plays a tumor-suppressor role in hepatocellular carcinoma (HCC), in which METTL14 and m6A levels were decreased compared to normal tissue or paratumor controls, with largely unchanged levels of METTL3 and WTAP. Here, METTL3 is linked to hepatocellular carcinoma.